Page last updated: 2024-10-17

3,4-dihydroxyphenylacetic acid and ANS (Autonomic Nervous System) Diseases

3,4-dihydroxyphenylacetic acid has been researched along with ANS (Autonomic Nervous System) Diseases in 5 studies

3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.

Research Excerpts

ExcerptRelevanceReference
"The most common is Parkinson's disease (PD), in which putamen dopamine content is drastically reduced."2.66The "Sick-but-not-Dead" Phenomenon Applied to Catecholamine Deficiency in Neurodegenerative Diseases. ( Goldstein, DS, 2020)
"Pure autonomic failure (PAF) and Parkinson's disease (PD) share several clinical laboratory abnormalities; however, PAF is not associated with parkinsonism."1.35Central dopamine deficiency in pure autonomic failure. ( Bernson, M; Carmona, G; Goldstein, DS; Holmes, C; Imrich, R; Mizrahi, N; Sato, T; Sharabi, Y; Vortmeyer, AO, 2008)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's2 (40.00)29.6817
2010's0 (0.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Goldstein, DS3
Sun, J1
He, C1
Yan, QX1
Wang, HD1
Li, KX1
Sun, X1
Feng, Y1
Zha, RR1
Cui, CP1
Xiong, X1
Gao, S1
Wang, X1
Yin, RX1
Qiao, GF1
Li, BY1
Holmes, C1
Sato, T1
Bernson, M1
Mizrahi, N1
Imrich, R1
Carmona, G1
Sharabi, Y1
Vortmeyer, AO1
Yamamoto, T1
Polinsky, RJ1
Baucom, CE1
Kopin, IJ1
Nakayama, H1
Inagaki, M1
Ito, S1
Gotoh, Y1
Oguchi, K1

Reviews

1 review available for 3,4-dihydroxyphenylacetic acid and ANS (Autonomic Nervous System) Diseases

ArticleYear
The "Sick-but-not-Dead" Phenomenon Applied to Catecholamine Deficiency in Neurodegenerative Diseases.
    Seminars in neurology, 2020, Volume: 40, Issue:5

    Topics: 3,4-Dihydroxyphenylacetic Acid; Autonomic Nervous System Diseases; Dopamine; Humans; Lewy Body Disea

2020

Other Studies

4 other studies available for 3,4-dihydroxyphenylacetic acid and ANS (Autonomic Nervous System) Diseases

ArticleYear
Parkinson-like early autonomic dysfunction induced by vagal application of DOPAL in rats.
    CNS neuroscience & therapeutics, 2021, Volume: 27, Issue:5

    Topics: 3,4-Dihydroxyphenylacetic Acid; alpha-Synuclein; Animals; Autonomic Nervous System Diseases; Baroref

2021
Central dopamine deficiency in pure autonomic failure.
    Clinical autonomic research : official journal of the Clinical Autonomic Research Society, 2008, Volume: 18, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Autonomic Nervous System Diseases; Brain; Catechols; Dihydroxy

2008
Plasma sulfoconjugated dopamine levels are normal in patients with autonomic failure.
    The Journal of laboratory and clinical medicine, 1996, Volume: 128, Issue:5

    Topics: 3,4-Dihydroxyphenylacetic Acid; Autonomic Nervous System Diseases; Case-Control Studies; Dihydroxyph

1996
Measurement of catecholamine metabolites: assessment of autonomic impairment in diabetic patients treated by hemodialysis.
    Nephron, 2000, Volume: 86, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Autonomic Nervous System Diseases; Diabetic Neuropathies; Dopamine;

2000